Perceptive Advisors

Last updated

Perceptive Advisors LLC
Company type Private
Industry Investment management
FoundedJuly 1999;24 years ago (1999-07)
Founder Joseph Edelman
Headquarters 51 Astor Place, New York City, New York, U.S.
Key people
Joseph Edelman (CEO)
Products Hedge fund
Venture capital
Private equity
Private credit
AUM US$9.5 billion (March 2023)
Number of employees
39 (March 2023)
Website www.perceptivelife.com
Footnotes /references
[1]

Perceptive Advisors ("Perceptive") is an American investment firm headquartered in New York City. It is focused on making public and private investments in the healthcare and biotechnology industries.

Contents

Background

Perceptive Advisors was founded in July 1999 by Joseph Edelman. Edelman was previously a senior analyst at Aries Fund, a Paramount Capital Asset Management biotechnology hedge fund as well as a senior bBiotechnology analyst at Prudential Securities. His father was Isidore Edelman, a physician and researcher who became chair of the biochemistry and molecular biophysics department at Columbia University. [2] [3] [4]

The firm's flagship fund is called the Perceptive Life Sciences Fund. The firm takes a high risk approach to investing as the biotech sector is considered very volatile and it take years to develop a drug that could be rejected by the Food and Drug Administration. The firm tends to focus on small and midcap companies and it may overpay for securities if it there is still growth potential or undersell securities if they have further downside potential. To help mitigate day-to-day volatility, it has set a maximum daily loss allowance of five percent on long and short positions. [2]

In 2013, Perceptive launched its first credit fund, Perceptive Credit Opportunities Fund which raised $323 million. It would invest in vehicles such as direct secured loans, royalties and convertible structures for public and private companies. [2] [4]

In August 2018, Institutional Investor stated that Perceptive since inception only had two years of negative returns. It had lost 10.33% in 2002 and 23.98% in 2008. [2]

In December 2019, Perceptive partnered with Xontogeny, a biotech startup accelerator to launch its first venture capital fund, Perceptive Xontogeny Venture Fund which raised $210 million. The fund would invest in biotech companies that were in preclinical development stage and help them move into the early clinical development stages. Prior to that Perceptive invested mainly in later-stage companies. [2] [5] [6]

At the end of 2022, it was reported that Perceptive posted losses of more than 40% during the last two years. These were considered the worst losses in the firm's history. [7] [8] [9]

SEC SPAC fine

In September 2022, the U.S. Securities and Exchange Commission sued Perceptive for failing to disclose conflicts of interest related to special-purpose acquisition companies (SPACs). It claimed in 2020, Perceptive advised its clients to invest in a series of SPACs without disclosing they were owned by both the firm's personnel and a private fund it had advised. Perceptive agreed to pay a $1.5 million fine to settle the case. [10] [11] [12]

Related Research Articles

A hedge fund is a pooled investment fund that holds liquid assets and that makes use of complex trading and risk management techniques to improve investment performance and insulate returns from market risk. Among these portfolio techniques are short selling and the use of leverage and derivative instruments. In the United States, financial regulations require that hedge funds be marketed only to institutional investors and high-net-worth individuals.

<span class="mw-page-title-main">U.S. Securities and Exchange Commission</span> Government agency overseeing stock exchanges

The U.S. Securities and Exchange Commission (SEC) is an independent agency of the United States federal government, created in the aftermath of the Wall Street Crash of 1929. The primary purpose of the SEC is to enforce the law against market manipulation.

In the field of finance, private equity (PE) is stock in a private company that does not offer stock to the general public. Private equity is offered instead to specialized investment funds and limited partnerships that take an active role in the management and structuring of the companies. In casual usage, "private equity" can refer to these investment firms rather than the companies that they invest in.

The 2003 mutual fund scandal was the result of the discovery of illegal late trading and market timing practices on the part of certain hedge fund and mutual fund companies.

The Investment Company Act of 1940 is an act of Congress which regulates investment funds. It was passed as a United States Public Law on August 22, 1940, and is codified at 15 U.S.C. §§ 80a-1–80a-64. Along with the Securities Exchange Act of 1934, the Investment Advisers Act of 1940, and extensive rules issued by the U.S. Securities and Exchange Commission; it is central to financial regulation in the United States. It has been updated by the Dodd-Frank Act of 2010. It is the primary source of regulation for mutual funds and closed-end funds, now a multi-trillion dollar investment industry. The 1940 Act also impacts the operations of hedge funds, private equity funds and even holding companies.

A special purpose acquisition company, also known as a "blank check company", is a shell corporation listed on a stock exchange with the purpose of acquiring a private company, thus making the private company public without going through the initial public offering process, which often carries significant procedural and regulatory burdens. According to the U.S. Securities and Exchange Commission (SEC), SPACs are created specifically to pool funds to finance a future merger or acquisition opportunity within a set timeframe; these opportunities usually have yet to be identified while raising funds.

SWORD-financing is a special form of financing invented to help junior biotech companies access institutional capital markets to finance their research and development (R&D) via establishing a special purpose entity and giving the investors partial rights to the outcomes of the R&D projects that they are funding.

Elliott Investment Management is an American investment management firm. It is also one of the largest activist funds in the world.

<span class="mw-page-title-main">Pershing Square Capital Management</span> American hedge fund

Pershing Square Capital Management is an American hedge fund management company founded and run by Bill Ackman, headquartered in New York City.

<span class="mw-page-title-main">Chamath Palihapitiya</span> Sri Lankan-born businessman

Chamath Palihapitiya is a Sri Lankan-born Canadian and American venture capitalist, engineer, SPAC sponsor, founder and CEO of Social Capital. Palihapitiya was an early senior executive at Facebook, working at the company from 2007 to 2011. Following his departure from Facebook, Palihapitiya started The Social+Capital Partnership, through which he invested in several companies, including Yammer and Slack. He is a co-host of a technology podcast, All In, along with David Sacks, Jason Calacanis, and David Friedberg.

Ambit was an American pharmaceutical company focused on development of kinase inhibitor therapeutics to treat a variety of human diseases. As of March 2014, the company was based in San Diego, California, and consisted of a single facility. Ambit made an initial public offering in May 2013, and was listed on the NASDAQ exchange under the symbol "AMBI". Ambit was acquired by Daiichi Sankyo in 2014 and is no longer traded on the NASDAQ exchange.

Saba Capital Management (Saba) is a credit relative value focused hedge fund firm established in 2009. It also has strategies in tail hedge, closed-end funds and SPACs.

Ginkgo Bioworks is an American biotech company founded in 2008 by five scientists from MIT, headed by Jason Kelly. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021.

Tiger Global Management, LLC is an American investment firm founded by Chase Coleman III, a former Tiger Management employee under Julian Robertson, in March 2001. It mainly focuses on internet, software, consumer, and financial technology companies.

<span class="mw-page-title-main">OrbiMed</span> American investment firm

OrbiMed is an American investment firm based in New York City, United States. It is focused on making public and private investments in the Healthcare and Biotechnology industries. OrbiMed is considered to be one of the largest dedicated healthcare investment firms in the world.

Clover Health Investments, Corp is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Trump Media & Technology Group (TMTG), also known as T Media Tech LLC, is an American media and technology company founded in 2021 by former U.S. president Donald Trump. In October 2021, the company announced a proposed merger agreement with Digital World Acquisition Corp. (DWAC), a publicly traded special-purpose acquisition company intended to take TMTG public through an initial public offering. The merger had not been completed by August 2023, and two months later DWAC disclosed it was refunding the $1 billion it had raised from investors for TMTG.

<span class="mw-page-title-main">RA Capital Management</span> Healthcare investment firm in Boston

RA Capital Management is an American investment firm based in Boston. It is focused on making public and private investments in the Healthcare and Biotechnology industries.

<span class="mw-page-title-main">B. Riley Financial</span> American financial services company

B. Riley Financial is an American financial services company headquartered in Los Angeles, California. The company is known for its investment banking services regarding small cap companies as well as retail liquidation services. It has also acquired several organizations and companies in recent years.

References

  1. ↑ "Form ADV" (PDF). SEC.
  2. 1 2 3 4 5 "The 41% Man". Institutional Investor. August 13, 2018. Retrieved April 11, 2023.
  3. ↑ Roche, Julia La. "This hedge fund crushed the competition in 2015". Business Insider. Retrieved April 11, 2023.
  4. 1 2 Lawrence, Stacy (October 25, 2016). "Hedge fund Perceptive raises $323M life sciences debt fund". Fierce Biotech.
  5. ↑ "Hedge Fund Firm Perceptive Advisors Raises First VC Fund". Institutional Investor. December 10, 2019. Retrieved April 11, 2023.
  6. ↑ Al Idrus, Amirah (May 12, 2021). "Perceptive Advisors unveils $515M fund, its 2nd for early-stage biotechs". Fierce Biotech.
  7. ↑ Chung, Gregory Zuckerman and Juliet (December 5, 2021). "WSJ News Exclusive | Hedge Funds Suffer Big Losses on Biotech Rout". Wall Street Journal. Retrieved April 12, 2023.
  8. ↑ "Stock Hedge Funds Erase Billions With Another Year of Losses". Bloomberg.com. December 28, 2022. Retrieved April 11, 2023.
  9. ↑ "Perceptive Posts Biggest Loss in Its History". Institutional Investor. January 14, 2022. Retrieved April 11, 2023.
  10. ↑ "SEC Sues SPAC Adviser for Not Disclosing Conflicts of Interest". Bloomberg.com. September 6, 2022. Retrieved April 11, 2023.
  11. ↑ "SEC Charges Perceptive Advisors". Institutional Investor. September 6, 2022. Retrieved April 11, 2023.
  12. ↑ "Perceptive Advisors to pay $1.5m to settle SEC charges relating to SPAC conflicts of interest". Hedgeweek. September 7, 2022.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.